Back to Search Start Over

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Authors :
Flaig TW
Spiess PE
Agarwal N
Bangs R
Boorjian SA
Buyyounouski MK
Downs TM
Efstathiou JA
Friedlander T
Greenberg RE
Guru KA
Hahn N
Herr HW
Hoimes C
Inman BA
Jimbo M
Kader AK
Lele SM
Meeks JJ
Michalski J
Montgomery JS
Pagliaro LC
Pal SK
Patterson A
Petrylak DP
Plimack ER
Pohar KS
Porter MP
Preston MA
Sexton WJ
Siefker-Radtke AO
Tward J
Wile G
Johnson-Chilla A
Dwyer MA
Gurski LA
Source :
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2018 Sep; Vol. 16 (9), pp. 1041-1053.
Publication Year :
2018

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer. These NCCN Guidelines Insights discuss important updates to the 2018 version of the guidelines, including implications of the 8th edition of the AJCC Cancer Staging Manual on treatment of muscle-invasive bladder cancer and incorporating newly approved immune checkpoint inhibitor therapies into treatment options for patients with locally advanced or metastatic disease.<br /> (Copyright © 2018 by the National Comprehensive Cancer Network.)

Details

Language :
English
ISSN :
1540-1413
Volume :
16
Issue :
9
Database :
MEDLINE
Journal :
Journal of the National Comprehensive Cancer Network : JNCCN
Publication Type :
Academic Journal
Accession number :
30181416
Full Text :
https://doi.org/10.6004/jnccn.2018.0072